These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7752996)
1. Cyclosporine therapy for refractory Langerhans cell histiocytosis. Aricò M; Colella R; Conter V; Indolfi P; Pession A; Santoro N; Burgio GR Med Pediatr Oncol; 1995 Jul; 25(1):12-6. PubMed ID: 7752996 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A therapy for multisystem langerhans cell histiocytosis. Minkov M; Grois N; Broadbent V; Ceci A; Jakobson A; Ladisch S Med Pediatr Oncol; 1999 Nov; 33(5):482-5. PubMed ID: 10531573 [TBL] [Abstract][Full Text] [Related]
3. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540 [TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone. Körholz D; Janssen G; Göbel U Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876 [TBL] [Abstract][Full Text] [Related]
5. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Minkov M Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin. McCowage GB; Frush DP; Kurtzberg J J Pediatr Hematol Oncol; 1996 May; 18(2):154-8. PubMed ID: 8846128 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [TBL] [Abstract][Full Text] [Related]
8. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]. Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704 [TBL] [Abstract][Full Text] [Related]
9. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients]. Cao Q; Huang WY; Xu H; Zhou LJ Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862 [TBL] [Abstract][Full Text] [Related]
10. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Stine KC; Saylors RL; Williams LL; Becton DL Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735 [TBL] [Abstract][Full Text] [Related]
11. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265 [TBL] [Abstract][Full Text] [Related]
12. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Broadbent V; Pritchard J; Yeomans E Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842 [TBL] [Abstract][Full Text] [Related]
13. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children. Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol]. Huang JB; Xue HM; Chen YY; Huang K Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children. Mahdi G; Israel DM; Hassall E Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994 [TBL] [Abstract][Full Text] [Related]
16. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience. Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India. Narula G; Pradhan ND; Arora B; Banavali SD Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864 [TBL] [Abstract][Full Text] [Related]
18. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Viana MB; Oliveira BM; Silva CM; Rios Leite VH Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481 [TBL] [Abstract][Full Text] [Related]